How large is the North America heart valve devices market size, and why is it becoming a strategic priority for cardiovascular investors and innovators?

Market Scope, Size, and Strategic Importance

The North America heart valve devices market size reflects one of the most dynamic and innovation-led segments of the global cardiovascular devices industry. Heart valve diseases—particularly aortic stenosis and mitral regurgitation—are rising steadily across the United States and Canada due to aging demographics, lifestyle-related risk factors, and improved diagnostic rates. As a result, demand for both surgical and transcatheter heart valve solutions continues to accelerate.

Valued at USD 6.59 billion in 2025, the North America heart valve devices market size is projected to grow at a robust CAGR of 10.10% during 2026–2035, reaching approximately USD 17.25 billion by 2035. This strong expansion is underpinned by advancements in transcatheter aortic valve replacement (TAVR), expanding indications for minimally invasive procedures, and a favorable regulatory and reimbursement environment. For investors, analysts, and business decision-makers, the market offers a rare combination of scale, technological leadership, and long-term growth visibility.

What Does the North America Heart Valve Devices Market Include?

The North America heart valve devices market encompasses implantable medical devices designed to repair or replace diseased cardiac valves. These devices are critical in restoring normal blood flow, improving cardiac efficiency, and significantly enhancing patient survival and quality of life.

Key Components of the Market

• Surgical and transcatheter valve replacement devices

• Valve repair systems and accessories

• Mechanical and bioprosthetic heart valves

• Balloon valvuloplasty and catheter-based solutions

The market is closely linked to broader trends in minimally invasive cardiology, structural heart disease management, and value-based healthcare delivery.

How Big Is the North America Heart Valve Devices Market Size Today?

Market Size and Forecast Snapshot

• Market size (2025): USD 6.59 Billion

• Expected market size (2035): USD 17.25 Billion

• Forecast CAGR (2026–2035): 10.10%

The market’s near tripling over the forecast period highlights its resilience and attractiveness, particularly when compared with slower-growing segments of the medical device industry.

What Are the Key Growth Drivers Behind the North America Heart Valve Devices Market Size?

Why Is the Market Expanding So Rapidly?

1. Aging Population and Rising Disease Burden

• Increased prevalence of degenerative valve diseases

• Higher incidence of aortic stenosis among elderly patients

• Longer life expectancy driving procedural volumes

2. Advancements in Transcatheter Technologies

• Expansion of TAVR into intermediate- and low-risk patients

• Development of next-generation transcatheter mitral valve replacement (TMVR)

• Reduced procedural risks and shorter recovery times

3. Favorable Regulatory and Reimbursement Environment

• Supportive FDA approval pathways

• Strong reimbursement coverage for TAVR and valve repair procedures

• Encouragement of innovation and clinical research

4. High Awareness and Access to Advanced Cardiac Care

• Concentration of specialized cardiac centers

• Multidisciplinary heart teams improving outcomes

• High patient acceptance of minimally invasive options

What Emerging Trends Are Shaping the North America Heart Valve Devices Market Size?

How Is Technology Redefining Market Growth?

Shift Toward Minimally Invasive Procedures

• TAVR increasingly replacing open-heart surgery

• Growing use of catheter-based mitral and tricuspid interventions

Rising Preference for Bioprosthetic Valves

• No requirement for lifelong anticoagulation

• Improved durability of tissue valves

• Better patient compliance and quality of life

Innovation in Valve Design and Materials

• Enhanced sealing mechanisms to reduce leakage

• Smaller delivery systems enabling broader patient eligibility

• Improved hemodynamic performance

Integration of Digital and Imaging Technologies

• Advanced imaging for procedural planning

• AI-driven analytics for patient selection and valve sizing

How Is the North America Heart Valve Devices Market Segmented by Valve Type?

Which Valve Types Contribute Most to Market Size?

Biological (Tissue) Valves

• Largest and fastest-growing segment

• Widely used in elderly and low-risk patients

• Strong alignment with transcatheter technologies

Key advantages include:

• Reduced thrombosis risk

• No long-term anticoagulation

• Improved lifestyle outcomes

Mechanical Valves

• Known for long-term durability

• Preferred in younger patient populations

• Slower growth due to anticoagulation requirements

How Is the Market Segmented by Product Type?

Which Products Drive Revenue Growth?

Replacement Devices

This is the dominant product category and includes:

• Mechanical valves

• Bioprosthetic valves

• Transcatheter Aortic Valve Replacement (TAVR)

TAVR accounts for the largest share of revenue, supported by expanding indications and strong reimbursement.

Repair Devices

• Surgical valve repair systems

• Transcatheter Mitral Valve Replacement (TMVR)

• Balloon valvuloplasty devices

Repair devices are gaining traction as clinicians emphasize valve preservation and minimally invasive approaches.

How Is the North America Heart Valve Devices Market Segmented by Procedure?

Which Procedures Are Most Common?

Open Surgery

• Traditional and well-established approach

• Declining share due to invasiveness

• Still required for complex or multi-valve cases

Minimally Invasive Surgery (MIS)

• Fastest-growing procedural segment

• Includes TAVR, TMVR, and catheter-based repairs

• Reduced hospital stays and complication rates

How Is the Market Segmented by End User?

Who Are the Primary End Users?

Hospitals

• Largest end-user segment

• High procedural volumes

• Availability of advanced cardiac infrastructure

Ambulatory Surgical Centers (ASCs)

• Increasing adoption of minimally invasive procedures

• Cost-effective care settings

• Limited to less complex interventions

Others

• Specialty cardiac centers and research institutions

What Are the Regional Insights Within North America?

How Do the United States and Canada Compare?

United States

• Accounts for the majority of the North America heart valve devices market size

• High adoption of TAVR and advanced technologies

• Strong private and public reimbursement frameworks

Canada

• Growing market with increasing transcatheter adoption

• Public healthcare system emphasizing cost-effectiveness

• Rising investments in cardiac care infrastructure

Who Are the Major Players in the North America Heart Valve Devices Market?

Competitive Landscape Overview

The market is highly competitive and innovation-driven, dominated by global cardiovascular device leaders with strong clinical pipelines.

Companies Covered

• Medtronic plc

• Edwards Lifesciences Corporation

• Abbott

• Corcym Group

• Boston Scientific Corporation

• Artivion, Inc.

• Micro Interventional Devices, Incorporated

• Shockwave Medical Inc. (Johnson & Johnson Services Inc.)

• JenaValve Technology, Inc.

Key Competitive Strategies

• Continuous R&D investment

• Expansion of transcatheter portfolios

• Strategic partnerships and acquisitions

• Focus on long-term valve durability

What Challenges and Restraints Affect the North America Heart Valve Devices Market Size?

Key Market Constraints

High Cost of Advanced Valve Devices

• Budget pressures on healthcare providers

• Scrutiny from payers and policymakers

Regulatory and Clinical Complexity

• Lengthy clinical trial requirements

• Stringent safety and efficacy standards

Durability Concerns in Younger Patients

• Ongoing evaluation of long-term outcomes

• Impact on adoption in low-risk populations

Access Disparities

• Limited availability in rural or underserved regions

What Is the Future Outlook for the North America Heart Valve Devices Market Size?

Market Outlook Through 2035

The North America heart valve devices market size is expected to expand steadily, supported by:

• Continued dominance of minimally invasive procedures

• Broader patient eligibility for transcatheter therapies

• Strong innovation pipelines from leading manufacturers

Future growth opportunities include:

• Valve-in-valve procedures

• Fully percutaneous mitral and tricuspid solutions

• AI-assisted procedural planning

• Expansion into younger and lower-risk patient groups

Browse More Reports

Healthcare Cloud Computing Market

Medical Spa Market

Assisted Reproductive Technology Market

Cannabis Market

About Us:

Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.

Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.

Media Contact:

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com